Research2Guidance March 24, 2024
Chronic respiratory diseases affect approximately 500 million individuals worldwide and are often linked with heart failure. In the United States, COPD and Chronic Heart Failure (CHF) alone account for a combined annual cost exceeding $100 billion. In light of this significant impact, how does NuvoAir Medical redefine chronic heart and lung disease management with their value-based specialty care platform?
Chronic heart and lung diseases affect millions worldwide, posing significant challenges to both individuals and healthcare systems. Limited access to specialized care aggravates patient burdens and drives up healthcare costs. Conventional care approaches frequently lack continuous monitoring and prompt interventions, resulting in suboptimal outcomes and unnecessary hospitalizations.
Proactive monitoring solutions, utilizing user-friendly devices like spirometers, blood pressure cuffs, and activity trackers,...
Today's Sponsors
Today's Sponsor